Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pioneering Research to Optimize Pre-exposure Prophylaxis (PrEP) Expansion With Lenacapavir (LEN)

NCT07473778 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT07473778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07473778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pioneering Research to Optimize Pre-exposure Prophylaxis (PrEP) Expansion With Lenacapavir (LEN)
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Recruiting
Start date
March 17, 2026
Completion date
April 30, 2029
Enrollment
3,000 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections